… reduce the risk of pulmonary fibrosis in severe cases of COVID-19; however, … COVID-19
with ARDS [18]. This review provides an overview of pulmonary fibrosis resulting from COVID-19 …

… -COVID-19 pulmonary fibrosis and the potential risk factors. … ; Pulmonary fibrosis is a frequently
reported COVID-19 sequela … the prevalence of post-COVID-19 pulmonary fibrosis (PCPF) …

… cases worldwide, even small proportion of post covid lung … covid pulmonary fibrosis. This
narrative review summarizes current clinical evidence regarding post COVID-19 pulmonary …

… : COVID-19, COVID-19 pulmonary manifestations, COVID-19 extra pulmonary manifestations,
and pathophysiology of COVID-19… as follows: Is COVID-19 a respiratory disease only? and …

… the pulmonary sequelae, most notably pulmonary fibrosis (PF) [2]. Given that survivors of
COVID-19 who develop persistent pulmonary disease … with post-COVID-19 pulmonary fibrosis (…

… Our study evaluates coronavirus disease 19 (COVID-19) associated invasive … of 19 COVID-19
patients with moderate to severe ARDS without underlying immunocompromising disease …

… of this emerging disease and could help to ensure … pulmonary impairments, as well as the
prevalence of other organ dysfunctions and psychological disorders in patients with COVID-19 …

… complications after coronavirus 2019 disease (COVID-19) resolution … with post COVID-19
short-term pulmonary complications. … of COVID-19, patients may experience severe pulmonary …

… The incidence of IPA in COVID-19 ranged from 19.6% to 33.3… causing co-infection in COVID-19
patients, followed by … of pulmonary aspergillosis in severe/critical COVID-19 patients, and …

… severe acute respiratory syndrome coronavirus 2 emerged in … had coronavirus disease–associated
pulmonary aspergillosis … of 10 days after coronavirus disease diagnosis. Aspergillus …